Companies / BOC Sciences / Efalizumab
BOC Sciences

Efalizumab | BOC Sciences

Efalizumab is an anti-CD11a monoclonal antibody that has been approved for the treatment of psoriasis.

Reviews


No reviews yet

ABOUT THE COMPANY

BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.